Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FU9SB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,654
Award facts
- Contract value 100% obligated
- $10,654.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,654.33 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on July 30, 2025, with completion targeted for July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, serves military and veteran healthcare systems through its comprehensive IDC vehicle. The SPE2DX contract encompasses a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. Dupixent is a brand-name biologic medication used to treat conditions including atopic dermatitis, asthma, and eosinophilic esophagitis. This delivery order reflects the routine pharmaceutical procurement activities executed under the broader DLA framework to maintain medical supply chain readiness for federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FU9SB?
SPE2DB25FU9SB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FU9SB worth?
The government has obligated $10,654 on SPE2DB25FU9SB.
Is contract SPE2DB25FU9SB an order under another contract?
Yes. SPE2DB25FU9SB is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9SB competed?
The extent of competition for SPE2DB25FU9SB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award